Siemens Healthineers AG (0PMJ.L)
0PMJ.L Stock Price Chart
Explore Siemens Healthineers AG interactive price chart. Choose custom timeframes to analyze 0PMJ.L price movements and trends.
0PMJ.L Company Profile
Discover essential business fundamentals and corporate details for Siemens Healthineers AG (0PMJ.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
19 Jul 2018
Employees
72.00K
CEO
Bernhard Montag
Description
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
0PMJ.L Financial Timeline
Browse a chronological timeline of Siemens Healthineers AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 4 Feb 2026
Upcoming earnings on 5 Nov 2025
Upcoming earnings on 30 Jul 2025
Revenue estimate is €5.75B.
Earnings released on 5 May 2025
EPS came in at €0.56 falling short of the estimated €0.57 by -1.06%, while revenue for the quarter reached €5.91B, beating expectations by +0.52%.
Dividend declared on 19 Feb 2025
A dividend of €0.95 per share was announced, adjusted to €0.95. The dividend was paid on 21 Feb 2025.
Earnings released on 6 Feb 2025
EPS came in at €0.42 falling short of the estimated €0.47 by -10.79%, while revenue for the quarter reached €5.48B, missing expectations by -6.55%.
Earnings released on 6 Nov 2024
EPS came in at €0.55 falling short of the estimated €0.64 by -14.35%, while revenue for the quarter reached €6.33B, beating expectations by +0.26%.
Earnings released on 31 Jul 2024
EPS came in at €0.42 falling short of the estimated €0.52 by -18.62%, while revenue for the quarter reached €5.42B, missing expectations by -2.08%.
Earnings released on 7 May 2024
EPS came in at €0.38 falling short of the estimated €0.51 by -25.64%, while revenue for the quarter reached €5.44B, missing expectations by -0.49%.
Dividend declared on 19 Apr 2024
A dividend of €0.95 per share was announced, adjusted to €0.95. The dividend was paid on 23 Apr 2024.
Earnings released on 12 Mar 2024
EPS came in at €0.38 falling short of the estimated €0.44 by -14.22%, while revenue for the quarter reached €5.18B, beating expectations by +0.66%.
Earnings released on 30 Sept 2023
EPS came in at €0.48 falling short of the estimated €0.58 by -17.51%, while revenue for the quarter reached €6.06B, beating expectations by +3.10%.
Earnings released on 30 Jun 2023
EPS came in at €0.40 falling short of the estimated €0.50 by -20.97%, while revenue for the quarter reached €5.20B, beating expectations by +0.99%.
Earnings released on 31 Mar 2023
EPS came in at €0.09 falling short of the estimated €0.43 by -78.02%, while revenue for the quarter reached €5.35B, beating expectations by +2.02%.
Dividend declared on 16 Feb 2023
A dividend of €0.95 per share was announced, adjusted to €0.95. The dividend was paid on 20 Feb 2023.
Earnings released on 31 Dec 2022
EPS came in at €0.38 falling short of the estimated €0.43 by -13.04%, while revenue for the quarter reached €5.08B, missing expectations by -3.61%.
Earnings released on 30 Sept 2022
EPS came in at €0.56 falling short of the estimated €0.59 by -4.92%, while revenue for the quarter reached €6.00B, beating expectations by +3.12%.
Earnings released on 30 Jun 2022
EPS came in at €0.32 falling short of the estimated €0.48 by -33.02%, while revenue for the quarter reached €5.19B, beating expectations by +2.20%.
Earnings released on 31 Mar 2022
EPS came in at €0.52 falling short of the estimated €0.55 by -6.19%, while revenue for the quarter reached €5.46B, beating expectations by +8.72%.
Dividend declared on 16 Feb 2022
A dividend of €0.85 per share was announced, adjusted to €0.85. The dividend was paid on 18 Feb 2022.
Earnings released on 31 Dec 2021
EPS came in at €0.42, while revenue for the quarter reached €5.07B.
Earnings released on 30 Sept 2021
EPS came in at €0.41 falling short of the estimated €0.51 by -18.51%, while revenue for the quarter reached €5.16B, beating expectations by +5.49%.
Earnings released on 30 Jun 2021
EPS came in at €0.35, while revenue for the quarter reached €5.00B.
Earnings released on 31 Mar 2021
EPS came in at €0.41, while revenue for the quarter reached €3.97B.
Dividend declared on 15 Feb 2021
A dividend of €0.80 per share was announced, adjusted to €0.80. The dividend was paid on 17 Feb 2021.
Earnings released on 31 Dec 2020
EPS came in at €0.40, while revenue for the quarter reached €3.87B.
Earnings released on 30 Sept 2020
EPS came in at €0.42, while revenue for the quarter reached €3.88B.
0PMJ.L Stock Performance
Access detailed 0PMJ.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.